All sections · Part XIII: Protected Cell Companies · Sub-Part V: Dealings with and Arrangements within Protected Cell Companies
237 告知与之打交道的人有受保护细胞的公司的公司
(1) 受保护的电池公司必须--
(a) 告知与它有业务往来的任何人，它是一家受保护的细胞公司；并且
(b) 为该交易的目的，确定或指明该人正在进行交易的单元，除非该交易不是针对某一特定单元的交易，在这种情况下，必须指明该交易与核心单元有关。
(2) Wenn, entgegen dem Absatz (1) , eine geschützte Zellfirma –
(a) 没有通知某人他或她正在与受保护的手机公司做生意，而该人不知道他或她正在与受保护的手机公司做生意，也没有合理的理由相信他或她正在这样做；或
(b) 没有确定或指明某人正在进行交易的单元或核心，而且该人不知道也没有合理的理由知道他或她正在与哪个单元或核心进行交易。
那么，无论在哪种情况下--
(i) 董事（尽管本公司的组织章程或章程细则或与本公司签订的任何合同或其他文件中有任何相反的规定）因交易而对该人产生个人责任；以及
(i) 董事有权以本公司的核心资产作为赔偿，除非他们有欺诈、鲁莽或疏忽的行为，或有不诚实的行为。
(3) 如果法院根据第350条，根据第(2)(i)款全部或部分解除董事的个人责任，法院可以命令有关的责任由条例中提到的受保护单元公司的单元或核心资产来承担。
(a) 告知与它有业务往来的任何人，它是一家受保护的细胞公司；并且
(b) 为该交易的目的，确定或指明该人正在进行交易的单元，除非该交易不是针对某一特定单元的交易，在这种情况下，必须指明该交易与核心单元有关。
(2) Wenn, entgegen dem Absatz (1) , eine geschützte Zellfirma –
(a) 没有通知某人他或她正在与受保护的手机公司做生意，而该人不知道他或她正在与受保护的手机公司做生意，也没有合理的理由相信他或她正在这样做；或
(b) 没有确定或指明某人正在进行交易的单元或核心，而且该人不知道也没有合理的理由知道他或她正在与哪个单元或核心进行交易。
那么，无论在哪种情况下--
(i) 董事（尽管本公司的组织章程或章程细则或与本公司签订的任何合同或其他文件中有任何相反的规定）因交易而对该人产生个人责任；以及
(i) 董事有权以本公司的核心资产作为赔偿，除非他们有欺诈、鲁莽或疏忽的行为，或有不诚实的行为。
(3) 如果法院根据第350条，根据第(2)(i)款全部或部分解除董事的个人责任，法院可以命令有关的责任由条例中提到的受保护单元公司的单元或核心资产来承担。
Translation for information only. Only the English original is legally binding.
Original wording (English, legally binding): Company to inform persons they are dealing with a protected cell company
(1) A protected cell company shall —
persons they are
dealing with a
(a) inform any person with whom it transacts that it is a protected
cell company; and
(b) for the purposes of that transaction, identify or specify the cell in
respect of which that person is transacting, unless that transaction
is not a transaction in respect of a particular cell, in which case it
shall specify that the transaction is in respect of the core.
(2) If, in contravention of subsection (1), a protected cell company —
(a) fails to inform a person that he is transacting with a protected
cell company, and that person is otherwise unaware that, and
has no reasonable grounds to believe that, he is transacting with
a protected cell company; or
(b) fails to identify or specify the cell or core, as the case may be,
in respect of which a person is transacting, and that person is
otherwise unaware of, and has no reasonable basis of knowing,
which cell or core, as the case may be, he is transacting with,
then, in either such case —
(i) the directors (notwithstanding any provision to the
contrary in the company‘s memorandum or articles or
in any contract with the company or otherwise) incur
personal liability to that person in respect of the
transaction; and
(ii) the directors have a right of indemnity against the core
assets of the company, unless they were fraudulent,
reckless or negligent, or acted in bad faith.
(3) Where, pursuant to section 350 the Court relieves a director of all or part
of his personal liability under subsection (2)(i), the Court may order that
the liability in question shall instead be met from such of the cellular or
core assets of the protected cell company as may be specified in the order.
persons they are
dealing with a
(a) inform any person with whom it transacts that it is a protected
cell company; and
(b) for the purposes of that transaction, identify or specify the cell in
respect of which that person is transacting, unless that transaction
is not a transaction in respect of a particular cell, in which case it
shall specify that the transaction is in respect of the core.
(2) If, in contravention of subsection (1), a protected cell company —
(a) fails to inform a person that he is transacting with a protected
cell company, and that person is otherwise unaware that, and
has no reasonable grounds to believe that, he is transacting with
a protected cell company; or
(b) fails to identify or specify the cell or core, as the case may be,
in respect of which a person is transacting, and that person is
otherwise unaware of, and has no reasonable basis of knowing,
which cell or core, as the case may be, he is transacting with,
then, in either such case —
(i) the directors (notwithstanding any provision to the
contrary in the company‘s memorandum or articles or
in any contract with the company or otherwise) incur
personal liability to that person in respect of the
transaction; and
(ii) the directors have a right of indemnity against the core
assets of the company, unless they were fraudulent,
reckless or negligent, or acted in bad faith.
(3) Where, pursuant to section 350 the Court relieves a director of all or part
of his personal liability under subsection (2)(i), the Court may order that
the liability in question shall instead be met from such of the cellular or
core assets of the protected cell company as may be specified in the order.
